The MD-6000 Bladder Scanner is a non-invasive diagnostic tool that measures the amount of urine in the bladder or used to determine how much urine remains in the bladder after urination as a way to ...
A phase 2 trial of enGene's detalimogene voraplasmid in non-muscle invasive bladder cancer (NMIBC) has delivered a positive result, setting it on course for a filing with the FDA next year. The LEGEND ...
Johnson & Johnson has brought its bladder cancer drug TAR-200 to the US market, a year after its prospects were dented by a negative phase 3 readout. The novel formulation of the stalwart ...
Bladder cancer arises from the lining of the bladder, the organ that stores urine, and is one of the most common cancers in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results